Skip to main content
Premium Trial:

Request an Annual Quote

Diagenic Exercises 10-for-1 Reverse Stock Split

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Diagenic recently announced a 10-for-1 reverse stock split, which took effect on May 30.

As a result of the split, each share of the company's stock was bumped up to NOK.50 ($.09) from NOK.05. After the split, the Norwegian firm had about 27 million shares of common stock outstanding.

The company develops diagnostic tests that measure disease-specific gene expression signatures in biofluids. It currently has two tests on the market, one for Alzheimer's disease and another for breast cancer.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.